 ROCKVILLE, Md., Nov. 23, 2020 PRNewswire -- REGENXBIO Inc. Nasdaq: RGNX, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, today announced it will present at the... 